InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 05/07/2019 10:00:40 AM

Tuesday, May 07, 2019 10:00:40 AM

Post# of 1237
News: $RTTR Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance

Top-line Data Readout on Target for early Q4 2019 LOS ANGELES, May 07, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut micr...

Find out more https://marketwirenews.com/news-releases/ritter-pharmaceuticals-completes-dosing-of-last-patient-in-pivotal-557-subject-phase-3-clinical-trial-of-rp-g28-in-patients-with-lactose-intolerance-8132634.html